Blueprint Medicines Corp
(BPMC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BPMC | ARWR | CYTK | ||
| Company | Blueprint Medicines Corp | Arrowhead Pharma | Cytokinetics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 129.35 | 61.13 | 65.49 | ||
| High | 129.55 | 64.48 | 67.54 | ||
| Low | 129.30 | 60.90 | 64.58 | ||
| Latest | 129.46 | 63.82 | 66.26 | ||
| Change | +0.18 | +1.44 | +1.22 | ||
| % Change | +0.14% | +2.31% | +1.88% | ||
| Volume | 2,980,900 | 1,990,700 | 2,080,100 | ||
| 20-Day Average Volume | 4,470,280 | 3,524,385 | 1,650,780 | ||
| Previous Close | 129.28 | 62.38 | 65.04 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 128.60 | 66.34 | 64.06 | ||
| 20-Day Raw Stochastic | 88.49% | 22.07% | 79.26% | ||
| 20-Day Relative Strength | 73.17 | 49.19 | 54.57 | ||
| Weighted Alpha | +17.08 | +212.92 | +28.20 | ||
| Today's Opinion | 100% Buy | 40% Buy | 96% Buy | ||
| Previous Opinion | 100% Buy | 40% Buy | 96% Buy | ||
| Last Month's Opinion | 100% Buy | 88% Buy | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.10% since 07/10/25 | -1.08% since 02/06/26 | +6.29% since 02/06/26 | ||
| Low | 129.00 on 07/11/25 | 60.34 on 02/11/26 | 61.58 on 02/09/26 | ||
| High | 129.65 on 07/16/25 | 65.09 on 02/09/26 | 67.89 on 02/12/26 | ||
| 1-Month | |||||
| %Chg | +0.96% since 06/17/25 | -2.63% since 01/13/26 | +4.63% since 01/13/26 | ||
| Low | 128.00 on 06/20/25 | 60.34 on 02/11/26 | 60.05 on 02/05/26 | ||
| High | 129.65 on 07/16/25 | 76.11 on 02/03/26 | 67.89 on 02/12/26 | ||
| 3-Month | |||||
| %Chg | +52.86% since 04/17/25 | +55.13% since 11/13/25 | +1.13% since 11/13/25 | ||
| Low | 83.27 on 04/22/25 | 37.06 on 11/20/25 | 58.85 on 01/05/26 | ||
| High | 129.65 on 07/16/25 | 76.76 on 01/06/26 | 70.98 on 12/22/25 | ||
| 6-Month | |||||
| %Chg | +17.64% since 01/17/25 | +219.26% since 08/13/25 | +79.66% since 08/13/25 | ||
| Low | 73.04 on 04/09/25 | 18.14 on 08/14/25 | 35.22 on 08/29/25 | ||
| High | 129.65 on 07/16/25 | 76.76 on 01/06/26 | 70.98 on 12/22/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,360,786 | 8,936,841 | 8,101,279 | ||
| Shares Outstanding, K | 64,582 | 140,032 | 122,265 | ||
| Annual Sales | 508,820,000 | 829,450,000 | 18,470,000 | ||
| Annual Net Income | -67,090,000 | -1,630,000 | -589,530,000 | ||
| Last Quarter Sales | 149,410,000 | 264,030,000 | 1,940,000 | ||
| Last Quarter Net Income | 500,000 | 30,810,000 | -306,180,000 | ||
| 60-Month Beta | 0.89 | 1.21 | 0.54 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.74 on 05/01/25 | 0.22 on 02/05/26 | -1.54 on 11/05/25 | ||
| Latest Earnings Date | 08/07/25 | 05/11/26 | 02/24/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 40.77 | 0.00 | ||